Yixian Cui

13PUBLICATIONS
25CO-AUTHORS
Epigenetics (incl. genome methylation and epigenomics)Microbial taxonomyMedical infection agents (incl. prions)Cancer cell biologyEnvironmental epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Oct 20, 2026
A USP28-TM9SF3-Golgiphagy axis maintains glycosylation homeostasis and promotes breast cancer progression.

|Jun 04, 2026
Reticulophagy limits Alzheimer's disease pathology through FAM134B-dependent APP clearance.

|May 26, 2026
FAM134B-mediated ER-phagy degrades APP and suppresses Alzheimer's disease pathology.

|Dec 09, 2025
CCPG1-mediated reticulophagy promotes tumorigenesis and cisplatin resistance in bladder cancer.

Yang Dong, Sufang Tian, Xueying Peng

|Jul 25, 2025
TM9SF3 is a mammalian Golgiphagy receptor that safeguards Golgi integrity and glycosylation fidelity.

Jiejie Yang, Yixian Cui

|Jul 04, 2024
Enhancing neuronal reticulophagy: a strategy for combating aging and APP toxicity.

Wenqing Mou, Yixian Cui

Pageof 3

Frequent Collaborators

3 joint publications

Xuehong Qian

2 joint publications

Smriti Parashar

2 joint publications

Susan Ferro-Novick

2 joint publications

Yang Cai